Managers / Q1 2026
Boomfish Wealth Group, LLC
CIK 0002010786 · 12600 DEERFIELD PARKWAY, SUITE 475, ALPHARETTA, GA, 30004 · 678-278-9632
Summary
Boomfish Wealth Group, LLC reported $187M in U.S.-listed holdings across 87 positions for Q1 2026.
Its largest position, Spdr Series, represents 5.5% of the portfolio.
Compared with Q4 2025, the fund opened 8 new positions and exited 6.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 71.6% · $134M
- ETP · 22.4% · $42M
- Other · 3.5% · $7M
- ADR · 1.5% · $3M
- REIT · 1.0% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| LINDE PLC | NEW | +2.8K | 2.8K | +$1M | $1M |
| AMDADVANCED MICRO DEVICES INC | NEW | +5.9K | 5.9K | +$1M | $1M |
| PIMCO ETF TR | NEW | +12.6K | 12.6K | +$1M | $1M |
| ISRGINTUITIVE SURGICAL INC | NEW | +2.2K | 2.2K | +$1M | $1M |
| SCHWAB STRATEGIC TR | NEW | +11.0K | 11.0K | +$293,881 | $293,881 |
| SCHWAB STRATEGIC TR | NEW | +9.3K | 9.3K | +$284,488 | $284,488 |
| ISHARES TR | NEW | +315 | 315 | +$205,682 | $205,682 |
| CRDLCARDIOL THERAPEUTICS INC | NEW | +14.4K | 14.4K | +$19,471 | $19,471 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $187M | 87 | Apr 22, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $187M | 85 | Jan 21, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $185M | 87 | Oct 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $173M | 87 | Jul 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $154M | 82 | Apr 18, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $165M | 93 | Jan 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $163M | 89 | Oct 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $155M | 86 | Jul 19, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $149M | 87 | May 3, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $139M | 83 | Feb 9, 2024 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.